{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:00:29Z","timestamp":1779894029336,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Liver disease is any condition that affects the liver cells and their function. It is directly linked to coagulation disorders since most coagulation factors are produced by the liver. Therefore, this study aimed to assess the magnitude and associated factors of coagulation abnormalities among liver disease patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted from August to October 2022 among 307 consecutively selected study participants at the University of Gondar Comprehensive Specialized Hospital. Sociodemographic and clinical data were collected using a structured questionnaire and data extraction sheet, respectively. About 2.7\u00a0mL of venous blood were collected and analyzed by the <jats:italic>Genrui CA51<\/jats:italic> coagulation analyzer. Data were entered into Epi-data and exported to STATA version 14 software for analysis. The finding was described in terms of frequencies and proportions. Factors associated with coagulation abnormalities were analyzed by bivariable and multivariable logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>In this study, a total of 307 study participants were included. Of them the magnitude of prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) were 68.08% and 63.51%, respectively. The presence of anaemia (AOR\u2009=\u20092.97, 95% CI: 1.26, 7.03), a lack of a vegetable feeding habit (AOR\u2009=\u20092.98, 95% CI: 1.42, 6.24), no history of blood transfusion (AOR\u2009=\u20093.72, 95% CI: 1.78, 7.78), and lack of physical exercise (AOR\u2009=\u20093.23, 95% CI: 1.60, 6.52) were significantly associated with prolonged PT. While the presence of anaemia (AOR\u2009=\u20093.02; 95% CI: 1.34, 6.76), lack of vegetable feeding habit (AOR\u2009=\u20092.64; 95% CI: 1.34, 5.20), no history of blood transfusion (AOR\u2009=\u20092.28; 95% CI: 1.09, 4.79), and a lack of physical exercise (AOR\u2009=\u20092.35; 95% CI: 1.16, 4.78) were significantly associated with abnormal APTT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with liver disease had substantial coagulation problems. Being anemic, having a transfusion history, lack of physical activity, and lack of vegetables showed significant association with coagulopathy. Therefore, early detection and management of coagulation abnormalities in liver disease patients are critical.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-023-00479-2","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:33:49Z","timestamp":1680518029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The magnitude and associated factors of coagulation abnormalities among liver disease patients at the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia, 2022"],"prefix":"10.1186","volume":"21","author":[{"given":"Abateneh","family":"Melkamu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berhanu","family":"Woldu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chomaw","family":"Sitotaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masresha","family":"Seyoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melak","family":"Aynalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"479_CR1","first-page":"1385","volume":"8","author":"S Krishnan","year":"2019","unstructured":"Krishnan S. Liver diseases-an overview. World J Pharm Pharmaceutical Sci. 2019;8:1385\u201395.","journal-title":"World J Pharm Pharmaceutical Sci"},{"issue":"5","key":"479_CR2","first-page":"756","volume":"74","author":"JJ Heidelbaugh","year":"2006","unstructured":"Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Am Fam Physician. 2006;74(5):756\u201362.","journal-title":"Am Fam Physician"},{"key":"479_CR3","unstructured":"Rifai N. Tietz textbook of clinical chemistry and molecular diagnostics. 7 ed: Elsevier Health Sciences; 2017. 1637 p."},{"key":"479_CR4","first-page":"2191","volume-title":"Williams hematology","author":"D Monroe","year":"2010","unstructured":"Monroe D, Hoffman M, Roberts H. Williams hematology. New York NY: McGraw-Hill Professional Publishing; 2010. p. 2191."},{"issue":"1","key":"479_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-2002-23205","volume":"22","author":"L Amitrano","year":"2002","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis. 2002;22(1):83\u201396.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"479_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/MOH.0000000000000164","volume":"22","author":"A Tripodi","year":"2015","unstructured":"Tripodi A. Hemostasis abnormalities in cirrhosis. Curr Opin Hematol. 2015;22(5):406\u201312.","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"479_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0019-5049.144643","volume":"58","author":"S Palta","year":"2014","unstructured":"Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515\u201323.","journal-title":"Indian J Anaesth"},{"issue":"Suppl 1","key":"479_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2036.2007.03509.x","volume":"26","author":"M Peck-Radosavljevic","year":"2007","unstructured":"Peck-Radosavljevic M. Review article: coagulation disorders in chronic liver disease. Aliment Pharmacol Ther. 2007;26(Suppl 1):21\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"479_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/asheducation-2015.1.243","volume":"2015","author":"JL Kujovich","year":"2015","unstructured":"Kujovich JL. Coagulopathy in liver disease: a balancing act. Hematology. 2015;2015(1):243\u20139.","journal-title":"Hematology"},{"issue":"1","key":"479_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MBC.0b013e32835975ed","volume":"24","author":"MFAA Saja","year":"2013","unstructured":"Saja MFAA, Sanai FM, Shaikh SA, Gader AGT. The coagulopathy of liver disease: does vitamin K help? Blood Coagul Fibrinolysis. 2013;24(1):10\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"479_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/hep.28628","volume":"64","author":"A Drolz","year":"2016","unstructured":"Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Kneidinger N, et al. Coagulation parameters and major bleeding in critically ill patients with cirrhosis. Hepatology. 2016;64(2):556\u201368.","journal-title":"Hepatology"},{"issue":"1","key":"479_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cld.2008.10.001","volume":"13","author":"SJ Munoz","year":"2009","unstructured":"Munoz SJ, Stravitz RT, Gabriel DA. Coagulopathy of acute liver failure. Clin Liver Dis. 2009;13(1):95\u2013107.","journal-title":"Clin Liver Dis"},{"key":"479_CR13","unstructured":"Fondu P, Thijs O. Haemostatic failure in liver disease: Springer Science & Business Media; 2012. 192 p."},{"key":"479_CR14","unstructured":"Atsede D. Tegegne MAN MKD, Kumela G. Nedessa, Hone M. Belaye https:\/\/mdl.donau-uni.ac.at\/ses\/pluginfile.php\/314\/mod_page\/content\/4\/CITY%20PROFILE%20GONDAR.pdf. City profile Gondar ( 29 October 2022)."},{"key":"479_CR15","doi-asserted-by":"crossref","unstructured":"Woldekidan NA, Mohammed AS. Clinical Knowledge and Practice of \u201cKetofol\u201d at University of Gondar Comprehensive Specialized Hospital. Frontiers in Medicine. 2021:1518.","DOI":"10.3389\/fmed.2021.555973"},{"issue":"1","key":"479_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s12877-021-02707-8","volume":"21","author":"X-X Dong","year":"2021","unstructured":"Dong X-X, Wang R-R, Liu J-Y, Ma Q-H, Pan C-W. Habitual tea consumption and 5-year incident metabolic syndrome among older adults: a community-based cohort study. BMC Geriatr. 2021;21(1):728.","journal-title":"BMC Geriatr"},{"issue":"6","key":"479_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11906-013-0386-8","volume":"15","author":"KM Diaz","year":"2013","unstructured":"Diaz KM, Shimbo D. Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013;15(6):659\u201368.","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"479_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11906-013-0386-8","volume":"15","author":"KMSD Diaz","year":"2013","unstructured":"Diaz KMSD. Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013;15(6):659\u201368.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"479_CR19","first-page":"1309","volume":"44","author":"D Pem","year":"2015","unstructured":"Pem D, Jeewon R. Fruit and Vegetable Intake: Benefits and Progress of Nutrition Education Interventions- Narrative Review Article. Iran J Public Health. 2015;44(10):1309\u201321.","journal-title":"Iran J Public Health"},{"key":"479_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/B978-0-12-375083-9.00184-7","volume-title":"Encyclopedia of Human Nutrition","author":"PA Lofgren","year":"2013","unstructured":"Lofgren PA. Meat, Poultry, and Meat Products: Nutritional Value. In: Caballero B, editor. Encyclopedia of Human Nutrition. 3rd ed. Waltham: Academic Press; 2013. p. 160\u20137.","edition":"3"},{"issue":"2","key":"479_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000517016","volume":"40","author":"D Mija\u010d","year":"2022","unstructured":"Mija\u010d D, Krsti\u0107 MN, Markovi\u0107 AP, Popovi\u0107 DD, Krsti\u0107 JM, Milosavljevi\u0107 T. Abnormal Liver blood tests: Primary care approach. Dig Dis. 2022;40(2):215\u201322.","journal-title":"Dig Dis"},{"issue":"4","key":"479_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131(4):417\u201330.","journal-title":"Br J Haematol"},{"issue":"6","key":"479_CR23","first-page":"11","volume":"69","author":"N Bohania","year":"2021","unstructured":"Bohania N, Agrawal A, Prakash A, Nangia A, Kumar A. Coagulation Profile and its Correlation with Severity of Liver Dysfunction and Gastrointestinal Bleed in Alcoholic Liver Disease Patients. J Assoc Physicians India. 2021;69(6):11\u20132.","journal-title":"J Assoc Physicians India"},{"key":"479_CR24","doi-asserted-by":"crossref","unstructured":"Yatish PA, Mudholkar Vishal G. The study of coagulation profile in patients of liver disease. Indian Journal of Pathology: Research and Practice. 2020;9(2 Part I).","DOI":"10.21088\/ijprp.2278.148X.9220.3"},{"key":"479_CR25","doi-asserted-by":"crossref","unstructured":"Chetali Rupela BV, Hansa Goswami. Coagulation profile in liver disease. International Journal of Current Research and Review. 2020;12(11).","DOI":"10.31782\/IJCRR.2020.12113"},{"issue":"4","key":"479_CR26","first-page":"554","volume":"5","author":"P Patel","year":"2018","unstructured":"Patel P, Mangar U, Patel R. Comparative study of coagulation profile in liver disease in tertiary care hospital. Indian J Pathol Oncol. 2018;5(4):554\u20137.","journal-title":"Indian J Pathol Oncol"},{"issue":"4","key":"479_CR27","first-page":"363","volume":"61","author":"SA Siddiqui","year":"2011","unstructured":"Siddiqui SA, Ahmed M, Ghani MH, Memon MA, Mustafa G, Ghori MA. Coagulation abnormalities in patients with chronic liver disease in Pakistan. J Pak Med Assoc. 2011;61(4):363\u20137.","journal-title":"J Pak Med Assoc"},{"issue":"8","key":"479_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.14260\/jemds\/2020\/123","volume":"9","author":"RP Garg","year":"2020","unstructured":"Garg RP, Agrawal A, Bhake AS, Vagha S. Correlation study of coagulation profile in spectrum of liver diseases. J Evol Med Dent Sci. 2020;9(8):549\u201355.","journal-title":"J Evol Med Dent Sci"},{"key":"479_CR29","doi-asserted-by":"crossref","unstructured":"Dr Shobhana Prajapati D, Manisha M Shah, Dr. Roopam K Gidwani, , Dr. Falguni Goswami DNVS, Dr. Ashok Prajapati and , Prajapati A. Coagulation profile in liver diseases: A study of 250 cases in a tertiary care hospital. international jounral of clinical and diagnostic pathology. 2020;3(3):185\u20138.","DOI":"10.33545\/pathol.2020.v3.i3c.280"},{"key":"479_CR30","first-page":"61","volume":"2","author":"G Bhatia","year":"2017","unstructured":"Bhatia G, Kaushik S, Kumar R, Kishore S, Bhatia U. Coagulation profile in liver diseases: a study of 300 cases in a tertiary care Hospital in Uttarakhand, India. Int J Adv Integr Med Sci. 2017;2:61\u20134.","journal-title":"Int J Adv Integr Med Sci"},{"issue":"7","key":"479_CR31","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/j.1537-2995.2010.02586.x","volume":"50","author":"WW Roeloffzen","year":"2010","unstructured":"Roeloffzen WW, Kluin-Nelemans HC, Bosman L, de Wolf JT. Effects of red blood cells on hemostasis. Transfusion. 2010;50(7):1536\u201344.","journal-title":"Transfusion"},{"issue":"7","key":"479_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/hep4.1725","volume":"5","author":"L Baiocchi","year":"2021","unstructured":"Baiocchi L, Glaser S, Francis H, Kennedy L, Felli E, Alpini G, et al. Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments. Hepatol Commun. 2021;5(7):1125\u201337.","journal-title":"Hepatol Commun"},{"issue":"8","key":"479_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.hpb.2016.05.011","volume":"18","author":"KP Cieslak","year":"2016","unstructured":"Cieslak KP, Baur O, Verheij J, Bennink RJ, van Gulik TM. Liver function declines with increased age. HPB (Oxford). 2016;18(8):691\u20136.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"479_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bjsm.37.5.433","volume":"37","author":"JE Smith","year":"2003","unstructured":"Smith JE. Effects of strenuous exercise on haemostasis. Br J Sports Med. 2003;37(5):433.","journal-title":"Br J Sports Med"},{"issue":"5","key":"479_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2165\/00007256-199622050-00002","volume":"22","author":"MS El-Sayed","year":"1996","unstructured":"El-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med. 1996;22(5):282\u201398.","journal-title":"Sports Med"},{"key":"479_CR36","unstructured":"Association for the advancement of blood biotherapies. Whole blood and red blood cell components 2022 [cited 2022 \/28\/10]. Available from: https:\/\/www.aabb.org\/regulatory-and-advocacy\/regulatory-affairs\/regulatory-for-blood\/whole-blood-and-red-blood-cell-components."},{"key":"479_CR37","doi-asserted-by":"crossref","unstructured":"Booth SL. Vitamin K: food composition and dietary intakes. Food Nutr Res. 2012;56.","DOI":"10.3402\/fnr.v56i0.5505"},{"key":"479_CR38","doi-asserted-by":"crossref","unstructured":"Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB. Postgraduate haematology: John Wiley & Sons; 2016.","DOI":"10.1002\/9781118853771"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-023-00479-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:37:48Z","timestamp":1680518268000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-023-00479-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1186\/s12959-023-00479-2","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethical clearance was obtained from the Ethics Review Committee of the School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar Research, with reference number SBMLS\/384\/2022. Then, a permission letter was secured from the UoG-CSH medical director. Before starting data collection, the data collectors were informed to ask permission, explain the purpose of the study and its importance and benefits, and offer to answer all the participants' questions to confirm their willingness. Then, written informed consent, or assent, was obtained. Participation in the study and refusals were possible. To ensure confidentiality of data, study participants were identified using codes, and unauthorised persons had no access to the data. All abnormal laboratory findings were linked to health professionals for proper management and treatment of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}